Skip to main content
. 2023 Jun 30;45(7):5534–5557. doi: 10.3390/cimb45070350

Table 3.

NOD-like receptors (NLR) and IBD. The proteins, the belonging families, functions and associated diseases are reported. MHC: major histocompatibility complex; NOD: Nucleotide-binding oligomerization domain; VAMAS1: Vitiligo-associated multiple autoimmune disease 1; MSPC: Multiple self-healing palmoplantar carcinoma; JRRP: Congenital juvenile recurrent respiratory papillomatosis; FMF: Familial Mediterranean Fever; FCAS: Familial cold autoinflammatory syndrome; AIADK: Autoinflammation with arthritis and dyskeratosis; MWS: Muckle-Wells syndrome; RA: Rheumatoid arthritis.

Family Protein Gene Mutation-Related Diseases IBD-Associated Function Complex
NLR MHC class II transactivator CIITA Bare lymphocyte syndrome
RA
Unknown Positive regulator of class II MHC
NLRB NRL family apoptosis inhibitory protein NAIP Spinal muscular atrophy Unknown Anti-apoptotic (inhibits CASP3, CASP7 and CASP9) Sensor component of NLRC4 that recognizes and binds CprI from pathogenic bacteria C. violaceum
NLRC NOD1 NOD1 IBD, Asthma, Behcet’s disease and sarcoidosis Yes Innate and adaptive immune responses and cellular homeostasis.
Binds bacterial peptidoglycans, single-stranded RNA (ssRNA) from viruses and the metabolite sphingosine-1-phosphate
Interacts with RIPK2 activating NF-kB and MAPK signaling pathways
NLRC NOD2 NOD2 Crohn’s disease and Blau syndrome Yes Innate and adaptive immune responses and cellular homeostasis.
Binds LPS by recognizing the muramyl dipeptide (MDP), single-stranded RNA (ssRNA) from viruses and the metabolite sphingosine-1-phosphate
Interacts with RIPK2 activating NF-kB and MAPK signaling pathways.
Interacts with NLRP1 leading to IL-1 release. Interacts with ATG16L1 leading to autophagy
NLRC NOD-like receptor caspase recruitment domain containing proteins 3–5 NLRC3 Yes Negative regulator of the innate immune response (negative regulation of NF-kB and type I interferon signaling pathways) Prevents NLRP3 inflammasome formation and may affect NOD1- or NOD2-mediated NF-kB activation
NRLC4 FCAS 4
Autoinflammation with infantile enterocolitis
Yes Innate immune response.
Promotes caspase-1 activation, cytokine production and macrophage pyroptosis
Homo-oligomerizes in the NLRC4 inflammasome and
enters the NRLP3 inflammasome
NRLC5 Pityriasis rubra pilaris
Bare lymphocytic syndrome type I
FMF
Unknown Negative regulator of the innate immune response (negative regulation of NF-kB and type I interferon signaling pathways)
NLRP NACHT, LRR, and PRD containing proteins 1–14 NLRP1-14 NRLP1: VAMAS1
MSPC
JRRP
Yes NLRP1: Innate immunity and inflammation.
Cytokines IL-1, IL-18 and
gasdermin-D (GSDMD), leading to pyroptosis, an inflammatory form of programmed cell death
NRLP1 inflammasome response to various pathogen-associated signals, recruits pro-caspase-1 (proCASP1) and promotes caspase-1 (CASP1) activation; may be activated by MDP in a NOD2-dependent manner
NRLP3:
FCAS1
AIADK
MWS
CINCA syndrome
Yes NLRP3: regulation of inflammation, immune response, and apoptosis. Stimulated by extracellular ATP, reactive oxygen species, K(+) efflux, crystals of monosodium urate or cholesterol, amyloid-beta fibers, environmental or industrial particles and nanoparticles, cytosolic dsRNA NRLP3 inflammasome upstream activator of NF-kappaB signaling
NLRP12:
FCAS2
Yes NLRP12 potent mitigator of inflammation
Primarily expressed in dendritic cells and macrophages, inhibits both canonical and non-canonical NF-kB and ERK activation pathways
Functions as a negative regulator of NOD2 by targeting it to degradation via the proteasome pathway.
Promotes bacterial tolerance
NLRX NOD-like receptor with “unknown” domain NLRX1 Histiocytic sarcoma
Combined oxidative phosphorylation deficiency 4
Mooren Ulcer
Mitochondrial Complex V Nuclear deficiency Type 3
Unknown Regulator of mitochondrial antivirus responses.
Promotes autophagy
Enhances NF-kB and JUN N-terminal kinase dependent signaling through the production of reactive oxygen species.
Regulates energy metabolism in a sex-dependent manner
Regulates NLRP3 inflammasome activation to attenuate apoptosis

Data from GeneCard®, The human gene database–https://www.genecards.org/ (accessed on 25 January 2023).